Investor Presentaiton

sanofi Play to Win: Leverage innovation to drive next growth chapter 2020-2022 Refocus with decisive actions Growth through winning assets Margin expansion 2023-2025 Transformative launches Agile and efficient resource deployment Leading R&D productivity Barring unforeseen events. 1. Sales from 2018. 9 Vaccines Investor Event Guidance of BOI margin of >32% by 2025 2026-2030 Industry leader in immunology with >€22bn sales by 2030 Doubling vaccines sales by 20301 No meaningful LOE Ambition to launch 3-5 new products with €2-5bn peak sales potential each

View entire presentation